This inventor holds 11 USPTO granted patents and 2 published patent applications. Top assignees: Pulsemedica Corp., University of Alberta, USA as Represented by Secretary of the Navy. Active years: 2006-2026.
Location History:
- Edmonton, CA (2006 - 2022)
- Alberta, CA (2024)
Company Filing History:
6 out of 8 
3 out of 455 
2 out of 16,275 Years Active: 2006-2026
Title: The Innovative Contributions of Abdulhakem Elezzabi
Introduction
Abdulhakem Elezzabi is a prominent inventor based in Edmonton, Canada. He has made significant contributions to the field of ophthalmology through his innovative inventions. With a total of 11 patents, Elezzabi has focused on developing advanced technologies for treating eye conditions.
Latest Patents
One of his latest patents is titled "Spatial light modulation targeting of therapeutic lasers for treatment of ophthalmological conditions." This invention allows a therapeutic laser to be modulated by a spatial light modulation device, enabling it to focus on multiple target locations simultaneously. Another notable patent is "Ophthalmological imaging and laser delivery device, system and methods." This system facilitates simultaneous imaging of an eye using both scanning laser ophthalmoscopy (SLO) and optical coherence tomography (OCT). Additionally, it is capable of targeting and delivering a treatment laser for eye conditions, incorporating a machine learning algorithm to suggest treatment procedures.
Career Highlights
Throughout his career, Elezzabi has worked with notable organizations such as PulseMedica Corp. and the University of Alberta. His work in these institutions has allowed him to collaborate with other experts in the field and further his research in ophthalmological technologies.
Collaborations
Some of his coworkers include Nir Katchinskiy and Mark B Johnson. Their collaboration has contributed to the advancement of technologies aimed at improving eye health.
Conclusion
Abdulhakem Elezzabi's innovative work in ophthalmology showcases his dedication to improving treatment methods for eye conditions. His patents reflect a commitment to advancing medical technology and enhancing patient care.